Mr Bi Huang
The First Affiliated Hospital of Chongqing Medical University, Chongqing (China)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry
Event: ESC Congress 2024
Topic: Cardio-Oncology
Session: Cardiovascular risk of cancer therapy
Machine learning identification of risk factors for ischaemic stroke in patients with heart failure with reduced ejection fraction but without atrial fibrillation: A report from WARCEF trial
Event: ESC Congress 2024
Topic: Diagnostic Methods
Session: New findings in stroke
Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry
Event: ESC Congress 2024
Topic: Antiarrhythmic Pharmacotherapy
Session: Novel and old treatments, evidence in large populations
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: implications of insulin treatment: a report from the GLORIA-AF Registry Phase III
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Integrated management of atrial fibrillation: addressing comorbidities, risk factors, and lifestyle
